| Name | 2-(4-(6-((5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethyl acetate |
|---|---|
| Synonyms |
Dashatinib impurity 43
2-(4-(6-((5-((2-Chloro-6-methylphenyl)cbamoyl)thiazol-2-yl)-amino)-2-methylpyrimidin-4-yl)pi 2-(4-(6-((5-((2-chloro-6-Methylphenyl)cbaMoyl)thiazol-2-yl)amino)-2-MethylpyriMidin-4-yl)piperazin-1-yl)ethyl acetate 5-Thiazolecboxamide, 2-[[6-[4-[2-(acetyloxy)ethyl]-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-N-(2-chloro-6-methylphenyl) Dasatinib Impurity K |
| Molecular Formula | C24H28ClN7O3S |
|---|---|
| Molecular Weight | 530.04200 |
| Exact Mass | 529.16600 |
| PSA | 140.82000 |
| LogP | 4.03320 |
|
~%
1245157-85-0 |
| Literature: Nanjing Cavendish Bio-Engineering Technology Co., Ltd.; Yan, Rong Patent: EP2532662 A1, 2012 ; |
|
~%
1245157-85-0 |
| Literature: Nanjing Cavendish Bio-Engineering Technology Co., Ltd.; Yan, Rong Patent: EP2532662 A1, 2012 ; |
|
~%
1245157-85-0 |
| Literature: Nanjing Cavendish Bio-Engineering Technology Co., Ltd.; Yan, Rong Patent: EP2532662 A1, 2012 ; |
| Precursor 3 | |
|---|---|
| DownStream 1 | |